Xenon Pharmaceuticals (XENE)
59.75
-0.65 (1.08%)
Upcoming Events
Latest Headlines
Xenon to Present at Wells Fargo Healthcare Conference
September 3, 2026 4:01 PM - StreetInsider
Form 144 Xenon Pharmaceuticals Filed by: KENNEY CHRISTOPHER JOHN
August 28, 2026 4:26 PM - SEC Filing
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 28, 2026 4:01 PM - StreetInsider
Xenon to present phase 3 azetukalner data at European Epilepsy Congress
August 26, 2026 4:01 PM - StreetInsider
Xenon to Highlight Phase 3 X-TOLE2 Clinical Data and Rational Polytherapy Potential for Azetukalner at EEC 2026
August 26, 2026 4:01 PM - StreetInsider
Form 4 Xenon Pharmaceuticals For: Aug 11 Filed by: GANNON STEVEN
August 13, 2026 4:35 PM - SEC Filing
Form 144 Xenon Pharmaceuticals Filed by: GANNON STEVEN
August 13, 2026 4:32 PM - SEC Filing
Form SCHEDULE 13G/A Xenon Pharmaceuticals Filed by: WELLINGTON MANAGEMENT GROUP LLP
August 13, 2026 4:10 PM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Xenon Pharmaceuticals (XENE)
August 10, 2026 6:41 AM - StreetInsider
Form SCHEDULE 13G/A Xenon Pharmaceuticals Filed by: FMR LLC
August 7, 2026 11:05 AM - SEC Filing
Xenon Pharmaceuticals (XENE) PT Lowered to $81 at RBC Capital
August 7, 2026 7:33 AM - StreetInsider
Form 10-Q Xenon Pharmaceuticals For: Jun 30
August 6, 2026 4:38 PM - SEC Filing
Xenon Pharmaceuticals (XENE) Tops Q2 EPS by 3c
August 6, 2026 4:22 PM - StreetInsider
Form 8-K Xenon Pharmaceuticals For: Aug 06
August 6, 2026 4:17 PM - SEC Filing
Xenon Reports Q2 2026 Financial Results and Provides Business Update
August 6, 2026 4:01 PM - StreetInsider
Form SCHEDULE 13G/A Xenon Pharmaceuticals Filed by: FMR LLC
August 6, 2026 10:44 AM - SEC Filing
F4 Begins Search for Radioactive Boulders at Todd and Wales Lake
August 4, 2026 7:02 AM - StreetInsider
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 31, 2026 4:01 PM - StreetInsider
Xenon to Report Q2 2026 Financial Results on August 6, 2026
July 30, 2026 4:01 PM - StreetInsider
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 2, 2026 4:01 PM - StreetInsider
Full Article List
